We often think of bone health or bone health concerns as this far away issue. But bone is constantly changing, and the ...
The U.S. Food and Drug Administration (FDA) on Friday approved Atebrioz (zilurgisertib) tablets, delivering a new once-daily oral treatment to patients suffering from fibrodysplasia ossificans ...
A new small molecule could treat and prevent excess bone formation. Fibrodysplasia ossificans progressiva (FOP) is an extremely rare disease estimated to affect about one in 2 million people worldwide ...
Researchers have synthesized nanoscale whitlockite, the second most abundant mineral in human bone, in milliseconds using ...
A new study of the PhyloBone project of the University of Turku, Finland, identifies hundreds of non-collagenous proteins in the bone matrix that may play regulatory roles in bone formation and ...
In a small study of 10 women, adding sugar to the surface of the patients' own bone marrow cells and administering them ...
A recent study identifies Neural EGFL-like 2 (NELL2), a secreted protein, as a key regulator of bone homeostasis, offering potential therapeutic applications for osteoporosis. NELL2 promotes ...
Health and Me on MSN
FDA approves new drug for rare disorder that turns muscles into bone: What is fibrodysplasia ossificans progressiva?
The US Food and Drug Administration recently approved the third drug to treat rare genetic disorder, fibrodysplasia ...
My son is undergoing treatment for neuroblastoma. As I have watched his illness for a long time, one question has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results